Exchange: OTC·Updated 03:34 PM EST

ELTP Elite Pharmaceuticals, Inc.

$0.37
$0.0451
(13.88%)
Today
EarningsFeb 15
Mkt Cap$350.1M
Vol1.91M

About ELTP

Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the following segments: Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
80

Extremely Bullish Sentiment

How do you feel about ELTP?

Bcardiner1
$ELTP One of the interesting aspects of the call, was they did get an offer and did NOT say it was not good, they just put it on hold to build out what is coming in 2027 and 2028 as well as there build out of more space. 2027 can be a banner year going into 2028... hoping before they uplist, they are at $1.00 or more.. that would be amazing.... and then the institutions can take a position and funds as well... this is amazing
12
Jackson1111
$ELTP I have only been in for 3years, many people much longer, I knew this would take time but the potential in this company was there, being patient is starting to pay off. The future is now visible.
7
bmarin62
$ELTP Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced results for the Second quarter of fiscal year 2027 ended September 30, 2026 ("Second Quarter"). Consolidated revenues for the three-month period ending September 30, 2026, were $40.1 million, an increase of $3.8 million or approximately 10.4% as compared to the same period of the prior fiscal year. This increase was primarily due to increased revenues from the Elite label amphetamine and naltrexone product lines, as compared to the same period of the prior fiscal year. Income from operations were $9.9 million, an increase of $1.7 million or approximately 21%, as compared to the same period of the prior fiscal year. Net income attributable to common shareholders was $17.3 million for the Second Quarter.
1
9
StoicStocks
$ELTP I bought more today, and will buy more tomorrow, and the next day, and the next day....
1
9
Zfresh
$ELTP the two additional board members they announced today have quite the resume! Something must be brewing. Added another 35,000 shares this morning. Earnings report should be next week. Hopefully we get good numbers and some positive news.
11
TraderDaKing
$ELTP $BTC.X Sold my Crypto and moved all-in on Pharma and Healthcare for 2027. Once the Democrats take office this sector will be the runner for the next several years.
5
BarkingPuppy
$ELTP $GME $BTC.X WHAT A GREAT DAY. On November 13, 2026, Elite Pharmaceuticals Inc (OTCPK: ELTP) announced its Q2 fiscal 2027 earnings, spotlighting a strategic shift in revenue sources driven by growth in addiction treatment segments and increased volumes in lisdexamfetamine. The company also revealed plans to pursue a NASDAQ listing by March 2027. GF Value™ indicates ELTP is approximately 40.9% undervalued, with a current price of $0.32 versus an intrinsic value estimate of $0.55. GF Score™ stands at 63/100, reflecting a moderate overall quality with strong financial strength and profitability. Insider activity shows net buying over the past 12 months, with insiders purchasing 130,000 shares and no insider selling reported.
8
TraderDaKing
$ELTP We should be back at .50 very soon. Today on the Conference call we got the best news ever. 2027 will be our year.
8
BarkingPuppy
$ELTP $GME $AMC Roaring Kitty is making a comeback. Its Starts with Elite. The “Roaring Kitty bought ELTP” claim appears to be an unverified social-media rumor, not confirmed news. The posts I found trace it to investor-forum chatter repeating the claim; I found some reliable confirmation from Keith Gill or a filing establishing that he bought ELTP. Big speculation about a relevant SEC filing coming in 2027. ELTP is Elite Pharmaceuticals, and social-media buzz is starting.
1
6
StoicStocks
$ELTP I have been out for a while, but I think it's time to get back in for a long hold. Give us Eliquis!!!
9
Sdk2424
$ELTP NASDAQ listing this spring will be the best path for investor success in more than 2 decades!! Glad I stuck around so long!!
7
deeplearner2021
$ELTP Is $4 the minimum to be listed on Nasdaq? Hakim mentioned in the Feb meeting that he wont consider a reverse split while the stock is traded in OTC, does that mean stock will organically reach $4 by March 2027?
1
2
BarkingPuppy
$ELTP This day will be marked as the First Day of the Great ELTP run into 2027. Congrats Longs.
6
StoicStocks
$ELTP Strong revenue growth and profit margins, ~$40M in cash and growing, very little debt, blockbuster potential in the pipeline. Management aligned with retail to up list without hurting shareholders. Only 5x P/E ratio. This will turn around very soon
7
TraderDaKing
$ELTP $GME Watch out for the Big Buys coming in........ The Kitten is getting ready to make Noise Blue Horseshoe Loves Elite Pharmaceuticals.
6
ValueInvestingEasily
$ELTP Eyeballing entry at these prices. Might wait until early 2027 though. I don’t know why they don’t do a 100:1 reverse split. Sure it would probably decrease because normally RS are a death kiss for a stock, but it would probably settle around $10-15 and would be eligible to be uplisted.
4
Target22
$ELTP I am expecting the company to announce a reverse split of 1-50 and a listing on Nasdaq on Friday's call. Brings share count down to 21m at about $10 a share. Then we might see some buying.
1
chowderhound
$ELTP with this news you'd think more buyers would just drop $100 on it to quadruple it in a few months. The upside is amazing! $SLS $POLA $SRXH
1
Mosley308
$ELTP SP sinking before going into news is a very bad sign. Since we usually have a sell-off after news release, my guess will drop even further.
1

Advertisement|Remove ads.